We are live on ! Find out more
CF

Corebridge Financial Portfolio holdings

AUM $4.25M
1-Year Est. Return 33.15%
This Fund
S&P 500
This Quarter Est. Return
+7.52%
1 Year Est. Return
-33.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$18.7B
AUM Growth
+$539M
Cap. Flow
-$486M
Cap. Flow %
-2.59%
Top 10 Hldgs %
25.55%
Holding
3,078
New
21
Increased
334
Reduced
2,669
Closed
33

Top Buys

Rank Stock Value
1
AVTR icon
Avantor
AVTR
+$19.6M
2
PLTR icon
Palantir
PLTR
+$15.2M
3
AAPL icon
Apple
AAPL
+$12.8M
4
CNH
CNH Industrial
CNH
+$10.5M
5
WAL icon
Western Alliance Bancorporation
WAL
+$9.86M

Sector Composition

Rank Sector Weight
1 Technology 28.58%
2 Financials 12.72%
3 Healthcare 11.35%
4 Consumer Discretionary 11.12%
5 Industrials 10.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INBX icon
2626
Inhibrx
INBX
$1.61B
$97.1K ﹤0.01%
6,201
+569
+10% +$8K
FET icon
2627
Forum Energy Technologies
FET
$952M
$96.9K ﹤0.01%
6,270
-39
-0.6% -$647
CFLT
2628
DELISTED
Confluent
CFLT
$96.9K ﹤0.01%
4,754
-54
-1% -$1.21K
OVLY icon
2629
Oak Valley Bancorp
OVLY
$291M
$96.8K ﹤0.01%
3,644
-22
-0.6% -$572
BRCC icon
2630
BRC Inc
BRCC
$122M
$96.7K ﹤0.01%
2,826
+25
+0.9% +$1.15K
ALTG icon
2631
Alta Equipment Group
ALTG
$192M
$96.7K ﹤0.01%
14,340
-89
-0.6% -$684
LXRX icon
2632
Lexicon Pharmaceuticals
LXRX
$890M
$96.4K ﹤0.01%
61,391
-379
-0.6% -$675
ZURA icon
2633
Zura Bio
ZURA
$499M
$96.4K ﹤0.01%
23,738
+12,970
+120% +$48.5K
RARE icon
2634
Ultragenyx Pharmaceutical
RARE
$1.41B
$96.2K ﹤0.01%
1,731
-5
-0.3% -$255
ORN icon
2635
Orion Group Holdings
ORN
$379M
$96.1K ﹤0.01%
16,647
+156
+0.9% +$1.2K
NNBR icon
2636
NN Inc
NNBR
$296M
$96K ﹤0.01%
24,622
-151
-0.6% -$544
ISTR icon
2637
Investar Holding Corp
ISTR
$425M
$95.9K ﹤0.01%
4,944
-31
-0.6% -$545
PYXS icon
2638
Pyxis Oncology
PYXS
$268M
$95.8K ﹤0.01%
26,112
-161
-0.6% -$563
STHO icon
2639
Star Holdings Shares of Beneficial Interest
STHO
$112M
$95.8K ﹤0.01%
6,924
-42
-0.6% -$545
NAGE
2640
Niagen Bioscience
NAGE
$241M
$95.5K ﹤0.01%
26,178
-161
-0.6% -$507
PESI icon
2641
Perma-Fix Environmental Services
PESI
$398M
$95.3K ﹤0.01%
7,768
+1,000
+15% +$10.7K
KRT icon
2642
Karat Packaging
KRT
$936M
$94.7K ﹤0.01%
3,658
-23
-0.6% -$616
OFLX icon
2643
Omega Flex
OFLX
$258M
$94.7K ﹤0.01%
1,897
-12
-0.6% -$591
VEL icon
2644
Velocity Financial
VEL
$709M
$94.4K ﹤0.01%
4,814
-30
-0.6% -$566
SEVN
2645
Seven Hills Realty Trust
SEVN
$168M
$94.1K ﹤0.01%
6,837
-43
-0.6% -$578
CTOS icon
2646
Custom Truck One Source
CTOS
$2.07B
$94.1K ﹤0.01%
27,276
-169
-0.6% -$710
ACTG icon
2647
Acacia Research
ACTG
$446M
$94.1K ﹤0.01%
20,187
-124
-0.6% -$613
CHGG icon
2648
Chegg
CHGG
$81.6M
$94K ﹤0.01%
53,087
-327
-0.6% -$801
IBEX icon
2649
IBEX
IBEX
$528M
$93.9K ﹤0.01%
4,698
-128
-3% -$2.2K
NATR icon
2650
Nature's Sunshine
NATR
$238M
$93.8K ﹤0.01%
6,889
-42
-0.6% -$602

Similar funds

Corebridge Financial's Q3 2024 Portfolio in Review

As of Q3 2024, Corebridge Financial held 3,078 positions worth $18.7B, up 3% from $18.2B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Trading was light in Q3 2024: portfolio turnover was 1.8%. Corebridge Financial opened 21 new positions and exited 33, leaving the 3,078-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 29% a quarter earlier, followed by Financials and Healthcare.

  • Corebridge Financial's largest Q3 2024 buy was Dell: 70,274 shares worth $8.33M.
  • Corebridge Financial added most to Avantor in Q3 2024, an estimated $19.6M increase.
  • Corebridge Financial's biggest Q3 2024 reduction was Microsoft, cutting an estimated $29.5M.
  • Corebridge Financial fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $10.1M.
  • Corebridge Financial's ten largest holdings make up 26% of its $18.7B portfolio in Q3 2024.
  • Corebridge Financial opened 21 new positions and closed 33 in Q3 2024.
  • Corebridge Financial's portfolio value rose 3% quarter-over-quarter to $18.7B.

Based on Corebridge Financial's 13F filing for Q3 2024, filed 13 Nov 2024.